Xcel Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Xcel Wealth Management's LLY Position: Q2 2026 in Review
Xcel Wealth Management increased its Eli Lilly (LLY) stake by 1.5% in Q2 2026, buying an estimated $6.13K and bringing the position to 394 shares worth $473K. The position accounts for 0.11% of the portfolio, ranked #106.
Xcel Wealth Management first reported a position in LLY in Q4 2018 and has held it in 24 quarters since. The position peaked at $951K in Q1 2022. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Xcel Wealth Management held 394 shares of Eli Lilly worth $473K as of Q2 2026.
- Xcel Wealth Management bought 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
- Eli Lilly made up 0.11% of Xcel Wealth Management's portfolio in Q2 2026, its #106 holding.
- Xcel Wealth Management first reported a position in Eli Lilly in Q4 2018 and has held it in 24 quarters since.
- Xcel Wealth Management's Eli Lilly position peaked at $951K in Q1 2022.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Xcel Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.